These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 26719256)

  • 1. Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain.
    Beatman EL; Massey A; Shives KD; Burrack KS; Chamanian M; Morrison TE; Beckham JD
    J Virol; 2015 Dec; 90(6):2767-82. PubMed ID: 26719256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology of West Nile Virus Infection and the Role of Alpha-Synuclein as a Viral Restriction Factor.
    Lesteberg KE; Beckham JD
    Viral Immunol; 2019; 32(1):38-47. PubMed ID: 30222521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic Innate Immune Responses Control Viral Growth and Protect against Neuronal Death in an
    Clarke P; Leser JS; Tyler KL
    J Virol; 2021 Aug; 95(18):e0083521. PubMed ID: 34190599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner.
    Lucas TM; Richner JM; Diamond MS
    J Virol; 2015 Dec; 90(5):2600-15. PubMed ID: 26699642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 limits cortical viral loads during West Nile virus infection of the central nervous system.
    Durrant DM; Daniels BP; Pasieka T; Dorsey D; Klein RS
    J Neuroinflammation; 2015 Dec; 12():233. PubMed ID: 26667390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.
    Samuel MA; Diamond MS
    J Virol; 2005 Nov; 79(21):13350-61. PubMed ID: 16227257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis.
    Sitati E; McCandless EE; Klein RS; Diamond MS
    J Virol; 2007 Sep; 81(18):9801-11. PubMed ID: 17626103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
    Gorman MJ; Poddar S; Farzan M; Diamond MS
    J Virol; 2016 Sep; 90(18):8212-25. PubMed ID: 27384652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
    Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
    J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms.
    Daffis S; Samuel MA; Keller BC; Gale M; Diamond MS
    PLoS Pathog; 2007 Jul; 3(7):e106. PubMed ID: 17676997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.
    Baer A; Lundberg L; Swales D; Waybright N; Pinkham C; Dinman JD; Jacobs JL; Kehn-Hall K
    J Virol; 2016 Jan; 90(7):3558-72. PubMed ID: 26792742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis.
    Samuel MA; Morrey JD; Diamond MS
    J Virol; 2007 Mar; 81(6):2614-23. PubMed ID: 17192305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING is required for host defense against neuropathological West Nile virus infection.
    McGuckin Wuertz K; Treuting PM; Hemann EA; Esser-Nobis K; Snyder AG; Graham JB; Daniels BP; Wilkins C; Snyder JM; Voss KM; Oberst A; Lund J; Gale M
    PLoS Pathog; 2019 Aug; 15(8):e1007899. PubMed ID: 31415679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons.
    Shrestha B; Pinto AK; Green S; Bosch I; Diamond MS
    J Virol; 2012 Sep; 86(17):8937-48. PubMed ID: 22740407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAVS Expressed by Hematopoietic Cells Is Critical for Control of West Nile Virus Infection and Pathogenesis.
    Zhao J; Vijay R; Zhao J; Gale M; Diamond MS; Perlman S
    J Virol; 2016 Aug; 90(16):7098-7108. PubMed ID: 27226371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis.
    Zhang B; Chan YK; Lu B; Diamond MS; Klein RS
    J Immunol; 2008 Feb; 180(4):2641-9. PubMed ID: 18250476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
    Svarcbahs R; Julku UH; Myöhänen TT
    J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system.
    Szretter KJ; Daffis S; Patel J; Suthar MS; Klein RS; Gale M; Diamond MS
    J Virol; 2010 Dec; 84(23):12125-38. PubMed ID: 20881045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
    Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
    Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals.
    Daniels BP; Holman DW; Cruz-Orengo L; Jujjavarapu H; Durrant DM; Klein RS
    mBio; 2014 Aug; 5(5):e01476-14. PubMed ID: 25161189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.